Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Shimadzu, Agilent, and More


Shimadzu has launched its new LCMS-8050 triple quadrupole.

The instrument offers attogram-level sensitivity along with a maximum scan rate of 30,000 u/second and a 5 millisecond polarity switching time and can perform up to 32,000 MRMs per analysis, the company said.

Agilent this week released its new AssayMAP peptide sample-prep system which offers automated protein digestion, peptide cleanup, and fractionation upfront of mass spec analysis.

The systems helps improve throughput and reproducibility of mass spec sample prep, addressing the bottleneck created by traditional sample prep methods, the company said.

Biognosys this week released a new version of its Spectronaut software that supports analysis of data independent acquisition mass spec data generated on Thermo Fisher Scientific's Q Exactive instrument.

Cell Signaling Technology has released its new HER3 rabbit monoclonal antibody for researcher studying HER2-mediated breast, lung, and ovarian tumors.

The antibody is primarily intended for immunohistochemistry and has also been validated for Western blotting, immunofluorescence, and flow cytometry and has been tested to ensure it has no cross-reactivity with other HER-family proteins, the company said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.